scPharmaceuticals OverviewscPharmaceuticals EBIT
EBIT (Earnings Before Interest and Taxes) analysis for SCPH.
Quarterly EBIT
-$14.36M
↑ 0.51% YoY
As of Jun 30, 2025
Annual EBIT (TTM)
-$67.54M
↓ 11.36% YoY
Trailing 12 months ending Jun 30, 2025
scPharmaceuticals OverviewEBIT (Earnings Before Interest and Taxes) analysis for SCPH.
As of Jun 30, 2025
Trailing 12 months ending Jun 30, 2025